Inovio shareholders elect eight directors, ratify auditor, approve executive compensation and equity plan

INOVIO PHARMACEUTICALS, INC.

Eight directors elected: each received 7.3M-8.4M votes for, 0.6M-1.7M withheld, 11M broker non-votes.
Ernst & Young ratified as auditor for FY2025: 19.3M for, 0.6M against, 0.2M abstain.
Advisory say-on-pay passed: 7.9M for, 1.1M against, 0.2M abstain, 11M broker non-votes.
Amendment and restatement of 2023 Omnibus Incentive Plan approved: 7.8M for, 1.2M against, 0.1M abstain.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.